E Hemminki

Author PubWeight™ 118.15‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Study of information submitted by drug companies to licensing authorities. Br Med J 1980 4.76
2 Suicides after pregnancy in Finland, 1987-94: register linkage study. BMJ 1996 2.79
3 Review of literature on the factors affecting drug prescribing. Soc Sci Med 1975 2.59
4 The role of prescriptions in therapy. Med Care 1975 2.40
5 Medical versus surgical termination of pregnancy in primigravid women--is the next delivery differently at risk? A population-based register study. BJOG 2012 2.12
6 Birth dimensions of offspring, premature birth, and the mortality of mothers. Lancet 2000 1.96
7 Could TH1 and TH2 diseases coexist? Evaluation of asthma incidence in children with coeliac disease, type 1 diabetes, or rheumatoid arthritis: a register study. J Allergy Clin Immunol 2001 1.93
8 Data quality after restructuring a national medical registry. Scand J Soc Med 1995 1.73
9 Terminations of pregnancy in the European Union. BJOG 2011 1.55
10 Routine administration of iron and vitamins during pregnancy: review of controlled clinical trials. Br J Obstet Gynaecol 1978 1.52
11 Can children's health be predicted by perinatal health? Int J Epidemiol 1999 1.49
12 Spontaneous abortions by occupation and social class in Finland. Int J Epidemiol 1980 1.48
13 The effect of a doctor's personal characteristics and working circumstances on the prescribing of psychotropic drugs. Med Care 1974 1.38
14 Content analysis of drug-detailing by pharmaceutical representatives. Med Educ 1977 1.37
15 Transplacental carcinogens and mutagens: childhood cancer, malformations, and abortions as risk indicators. J Toxicol Environ Health 1981 1.32
16 Declining induced abortion rate in Finland: data quality of the Finnish abortion register. Int J Epidemiol 1996 1.31
17 Associations of maternal age with maternity care use and birth outcomes in primiparous women: a comparison of results in 1991 and 2008 in Finland. BJOG 2013 1.27
18 Prevalence of menopause symptoms and their association with lifestyle among Finnish middle-aged women. Maturitas 2010 1.26
19 Prevention of low birth weight and pre-term birth: literature review and suggestions for research policy. Milbank Mem Fund Q Health Soc 1978 1.23
20 Prevention and treatment of premature labour by drugs: review of controlled clinical trials. Br J Obstet Gynaecol 1978 1.19
21 Effect of spectacle use and accommodation on myopic progression: final results of a three-year randomised clinical trial among schoolchildren. Br J Ophthalmol 1989 1.18
22 Register based monitoring shows decreasing socioeconomic differences in Finnish perinatal health. J Epidemiol Community Health 2003 1.18
23 Self-medication with vaginal antifungal drugs: physicians' experiences and women's utilization patterns. Fam Pract 2000 1.15
24 Trends in socioeconomic differences in Finnish perinatal health 1991-2006. J Epidemiol Community Health 2009 1.14
25 Polypharmacy among psychiatric patients. Acta Psychiatr Scand 1977 1.13
26 Frequency of daily over-the-counter drug use and potential clinically significant over-the-counter-prescription drug interactions in the Finnish adult population. Eur J Clin Pharmacol 2000 1.10
27 Perinatal mortality distributed by type of hospital in the Central Hospital District of Helsinki, Finland. Scand J Soc Med 1985 1.09
28 Patterns of use of obstetrical interventions in 12 countries. Paediatr Perinat Epidemiol 1993 1.07
29 Maternal predictors of perinatal mortality: the role of birthweight. Int J Epidemiol 1999 1.06
30 Social class differences in health until the age of seven years among the Finnish 1987 birth cohort. Soc Sci Med 1998 1.03
31 Growth, psychomotor development and morbidity up to 3 years of age in children born after IVF. Hum Reprod 2003 1.03
32 Is users' knowledge about contraceptives adequate? A case study of Finnish IUD users. Soc Sci Med 1992 1.03
33 Pregnancy-associated deaths in Finland 1987-1994--definition problems and benefits of record linkage. Acta Obstet Gynecol Scand 1997 1.02
34 Cancer morbidity in a cohort of 9175 Finnish women treated for infertility. Hum Reprod 2012 1.01
35 Birth outcomes by level of obstetric care in Finland: a catchment area based analysis. J Epidemiol Community Health 1994 1.01
36 Cesarean section and subsequent fertility: results from the 1982 National Survey of Family Growth. Fertil Steril 1985 1.00
37 Controlled trial on medical birth notification design. Methods Inf Med 1991 0.99
38 Effects of cesarean section on fertility and abortions. J Reprod Med 1986 0.98
39 Health care costs resulting from IVF: prenatal and neonatal periods. Hum Reprod 2004 0.97
40 The effect of antibiotics on mortality from infectious diseases in Sweden and Finland. Am J Public Health 1976 0.96
41 Women's decision-making in prenatal screening. Soc Sci Med 1998 0.95
42 Use of hormone replacement therapy in 1976-89 by 45-64 year old Finnish women. J Epidemiol Community Health 1991 0.95
43 Women's satisfaction with maternity health care services in Finland. Soc Sci Med 1993 0.94
44 Nordic Medical Birth Registers in epidemiological research. Eur J Epidemiol 1997 0.94
45 Boys have more health problems in childhood than girls: follow-up of the 1987 Finnish birth cohort. Acta Paediatr 1999 0.93
46 Accidental out-of-hospital births in Finland: incidence and geographical distribution 1963-1995. Acta Obstet Gynecol Scand 1999 0.93
47 Noninvestigational use of unapproved drugs--experience from the Scandinavian countries. Med Care 1981 0.92
48 Psychiatric disorders leading to hospitalization before and after infertility treatments. Hum Reprod 2010 0.92
49 Birth outcomes after induced abortion: a nationwide register-based study of first births in Finland. Hum Reprod 2012 0.91
50 In-vitro fertilization pregnancies and perinatal health in Finland 1991-1993. Hum Reprod 1995 0.91
51 Quality of reports of clinical trials submitted by the drug industry to the Finnish and Swedish control authorities. Eur J Clin Pharmacol 1981 0.90
52 The timing of hospital admission and progress of labour. Eur J Obstet Gynecol Reprod Biol 1986 0.89
53 Factors influencing drug prescribing--inquiry into research strategy. Drug Intell Clin Pharm 1976 0.89
54 Health registers as a feasible means of measuring health status in childhood--a 7-year follow-up of the 1987 Finnish birth cohort. Paediatr Perinat Epidemiol 1998 0.89
55 Amount of antenatal care and infant outcome. Eur J Obstet Gynecol Reprod Biol 1994 0.88
56 Self-medication of dyspepsia: how appropriate is it? Scand J Gastroenterol 1997 0.87
57 Obstetric practice in Finland, 1950-1980. Changes in technology and its relation to health. Med Care 1983 0.87
58 Knowledge and use of hormonal emergency contraception in Finland. Contraception 1997 0.87
59 Pregnancy weight gain from 1960s to 2000 in Finland. Int J Obes Relat Metab Disord 2003 0.86
60 Impact of induced abortions and statistical definitions on perinatal mortality figures. Paediatr Perinat Epidemiol 1994 0.86
61 Hysterectomy among Finnish women: prevalence and women's own opinions. Scand J Soc Med 1992 0.86
62 On what grounds do women participate in prenatal screening? Prenat Diagn 1998 0.85
63 Elderly people's compliance with prescriptions, and quality of medication. Scand J Soc Med 1975 0.85
64 Mortality in a cohort of IVF patients. Hum Reprod 2001 0.84
65 Diseases leading to psychotropic drug therapy. Scand J Soc Med 1974 0.84
66 Pregnancy and birth after cesarean section: a survey based on the Swedish birth register. Birth 1987 0.83
67 Why do women go along with this stuff? Birth 2006 0.83
68 The danger of overmatching in studies of the perinatal mortality and birthweight of infants born after assisted conception. Eur J Obstet Gynecol Reprod Biol 1996 0.83
69 An inquiry into associations between leading physicians and the drug industry in Finland. Soc Sci Med 1977 0.83
70 Alternative drug use for the climacteric in Finland. Maturitas 1997 0.83
71 Problems of clinical trials as evidence of therapeutic effectiveness. Soc Sci Med 1982 0.83
72 Feedback for participants in a health survey: feasible and useful. Women Health 1995 0.83
73 Spectacle-use, bifocals and prevention of myopic progression. The two-years results of a randomized trial among schoolchildren. Acta Ophthalmol Suppl 1988 0.83
74 Declining socioeconomic differences in the use of menopausal and postmenopausal hormone therapy in Finland. Maturitas 1999 0.83
75 Activity of enzymes related to neurotransmission in neuronal and glial fractions. Int J Neurosci 1973 0.82
76 Does hormone replacement therapy affect the use of prescription medicines in postmenopausal women: experience from the Estonian Postmenopausal Hormone Therapy Trial [ISRCTN35338757]. BJOG 2007 0.82
77 The quality of drug advertisements in two Finnish medical journals. A comparison between psychotropic and other drug advertisements. Soc Sci Med 1973 0.82
78 Ambulation versus oxytocin in protracted labour: a pilot study. Eur J Obstet Gynecol Reprod Biol 1985 0.82
79 Quality of care in abortion services in Finland. Acta Obstet Gynecol Scand 1998 0.82
80 Trade names and generic names. Problems for prescribing physicians. Scand J Prim Health Care 1984 0.82
81 Regional equity in childhood health--register-based follow-up of the Finnish 1987 birth cohort. Health Place 2000 0.82
82 Women's experiences of prenatal serum screening. Birth 1996 0.82
83 Infant care practices in rural China and their relation to prenatal care utilisation. Glob Public Health 2011 0.81
84 Participation in prenatal screening tests and intentions concerning selective termination in Finnish maternity care. Fetal Diagn Ther 1999 0.81
85 Physicians' attitudes toward reclassifying drugs as over-the-counter. Med Care 1999 0.81
86 Use of alternative drugs in Finland. Pharmacoepidemiol Drug Saf 1999 0.81
87 Increase in years of life after eliminating causes of death: significance for health priorities. Scand J Soc Med 1976 0.81
88 Contraceptive health risks--women's perceptions. J Psychosom Obstet Gynaecol 1998 0.81
89 The socioeconomic characteristics of risky sexual behaviour among reproductive-age women in St Petersburg. Scand J Public Health 2008 0.81
90 The use of combined estrogen-progestin replacement therapy. Int J Technol Assess Health Care 1988 0.80
91 Ambulation and delayed amniotomy in the first stage of labor. Eur J Obstet Gynecol Reprod Biol 1983 0.80
92 The function of drug company representatives. Scand J Soc Med 1977 0.80
93 Comparison between research data and routinely collected register data for studying childhood health. Eur J Epidemiol 2000 0.80
94 Is there a relation between waiting-list length and surgery rate? Int J Health Plann Manage 1994 0.80
95 Time trends of ectopic pregnancies. Br J Obstet Gynaecol 1987 0.79
96 Patient managed clinical trial. Control Clin Trials 1997 0.79
97 Patterns of prenatal care in the United States. J Public Health Policy 1987 0.79
98 The social aspects of drug use. WHO Reg Publ Eur Ser 1993 0.79
99 Drug reimbursement in four Nordic countries. Scand J Soc Med 1981 0.78
100 Incidence of placenta previa and abruptio placentae in New York State. N Y State J Med 1987 0.78
101 Practice of in-vitro fertilization: a case study from Finland. Soc Sci Med 1996 0.78
102 Finnish physicians' attitudes towards preconsultation information: menopausal treatment practices as an example. Patient Educ Couns 1998 0.77
103 Success of infertility treatments in Finland in the period 1992-2005. Eur J Obstet Gynecol Reprod Biol 2009 0.77
104 Trends in the use of climacteric and postclimacteric hormones in Nordic countries. Maturitas 1995 0.77
105 Medical students and drug promotion. Acad Med 1994 0.77
106 Careprovider and obstetrical interventions--a comparative study of four European countries. Scand J Caring Sci 1993 0.77
107 Physicians' gender and clinical opinions of reproductive health matters. Women Health 1997 0.77
108 Declining perinatal mortality in Finland between 1987 and 1994: contribution of different subgroups. Eur J Obstet Gynecol Reprod Biol 1998 0.77
109 Self medication and health habits in the management of upper gastrointestinal symptoms. Patient Educ Couns 1999 0.77
110 Prescription of antimicrobial drugs by general practitioners. Infection 1974 0.76
111 Finnish physicians' interest in genetic screening. Community Genet 2001 0.76
112 Use of supplement iron in pregnancy. Acta Obstet Gynecol Scand 2000 0.75
113 Oral contraceptives and breast cancer. BMJ 1996 0.75
114 International actors and population policies in India, with special reference to contraceptive policies. Int J Health Serv 2000 0.75
115 Prenatal screening and genetics. Eur J Public Health 2001 0.75
116 Recent endometrial cancer trends in Connecticut and prescriptions for estrogen replacement therapy. Int J Cancer 1989 0.75
117 [Reduction of the mortality rate in traffic acciddent in 1974 compared with the mortality rate in tuberculosis and with infant death]. Duodecim 1975 0.75
118 Caesarean section as a risk factor for malformations--a negative finding. Int J Epidemiol 1986 0.75
119 [Iron prophylaxis in pregnancy]. Duodecim 1986 0.75
120 Interest in alternative birth settings in Finland. Acta Obstet Gynecol Scand 1998 0.75
121 Tobacco, alcohol, medicines and illegal drug taking. Adolescence 1974 0.75
122 Assessing reproductive technology. A commentary. Int J Technol Assess Health Care 1999 0.75
123 [Life expectancy of the population and the influence of most occuring causes of death]. Duodecim 1974 0.75
124 Perceptions and satisfaction among Norplant users in Finland. Acta Obstet Gynecol Scand 1995 0.75
125 Acceptance of screening and abortion for Down syndrome among Finnish midwives and public health nurses. Prenat Diagn 1999 0.75
126 Does licensing of drugs in industrialized countries guarantee drug quality and safety for Third World countries? The case of norplant licensing in Finland. Int J Health Serv 1997 0.75
127 Secrecy in drug regulationLicensing documentation on the Norplant® contraceptive. Int J Risk Saf Med 1996 0.75
128 Diuretics in pregnancy: a case study of a worthless therapy. Soc Sci Med 1984 0.75
129 [Control of clinical drug trials in Finland, Norway and Sweden]. Nord Med 1981 0.75
130 Cosmetic and postmastectomy breast implants: Finnish women's experiences. J Womens Health Gend Based Med 1999 0.75
131 Births in Finland and Estonia from 1992 to 1996: convergent differences? BJOG 2000 0.75
132 Frequency of psychotropic drug prescribing for children in Tampere, Finland. Acta Paediatr Scand 1978 0.75
133 Pros and cons of intrauterine contraception--do perceptions of users and physicians differ? Scand J Prim Health Care 1994 0.75
134 [Parturients in 1988]. Duodecim 1992 0.75
135 [Newborns in the year 1987]. Duodecim 1991 0.75
136 Different contraceptive practices: use of contraceptives in Finland and other Nordic countries in the 1970s and 1980s. Scand J Soc Med 1991 0.75
137 Psychotropic drug registration in the Scandinavian countries: the role of clinical trials. Soc Sci Med Med Psychol Med Sociol 1980 0.75
138 [The importance of iron prophylaxis in pregnancy]. Katilolehti 1991 0.75
139 General practitioners' indications for psychotropic drugs. Scand J Soc Med 1974 0.75
140 The place of medical sociology. Scand J Soc Med 1988 0.75
141 Who uses Norplant. A study from Finland. Acta Obstet Gynecol Scand 1994 0.75
142 Hormone replacement therapy: discrepancies between evidence and recommendations. Scand J Public Health 2000 0.75
143 Pregnancy-related violent deaths. Scand J Public Health 1999 0.75
144 [Are there grounds for iron supplementation?]. Duodecim 1994 0.75
145 [Variations in obstetric interventions among various midwives]. Jordemodern 1993 0.75
146 Midwives as providers of prenatal care in Finland--past and present. Women Health 1992 0.75
147 Problems in the measurement of psychotropic drug consumption. Am J Hosp Pharm 1982 0.75
148 Variation in obstetric interventions by midwife. Scand J Caring Sci 1992 0.75
149 Number and type of psychotropic drugs on the Scandinavian market in 1950-1977. Drug Intell Clin Pharm 1981 0.75
150 Use of benzodiazepines in the Nordic countries in the 1960s and 1970s. Br J Addict 1983 0.75
151 Is menopause withering away? J Biosoc Sci 1995 0.75
152 Drug use among schoolchildren in Helsinki 1970. Br J Addict Alcohol Other Drugs 1973 0.75
153 Comparability of reasons for cesarean sections in patient records and mothers' interviews. Birth 1990 0.75
154 Regional coffee consumption and mortality from ischemic heart disease in Finland. Acta Med Scand 1977 0.75
155 Do young women have specific problems in contraceptive use and counselling? Eur J Obstet Gynecol Reprod Biol 1999 0.75
156 [More information about a case report]. Duodecim 1997 0.75
157 [Obstetric practice in Finland]. Katilolehti 1985 0.75
158 Adverse reactions to antibiotic drugs: the present scope of the problem in outpatient care and possibilities for improvement. Int J Health Serv 1981 0.75
159 [Supply and registration of drugs in the Scandinavian countries]. Nord Med 1980 0.75
160 [Maternity clinics in Finnish maternity care]. Katilolehti 1992 0.75
161 Quality of clinical trials--a concern of three decades. Methods Inf Med 1982 0.75
162 Knowledge of prenatal care among non-pregnant women: an explanation for early attendance. Scand J Soc Med 1996 0.75
163 [The support person at the delivery--a Finnish study]. Katilolehti 1992 0.75
164 Physicians' experience with Norplant implantable contraceptives in Finland. Scand J Soc Med 1995 0.75
165 Experience of Finnish women with Norplant insertions and removals. Br J Obstet Gynaecol 1997 0.75
166 Sales of psychotropic drugs in the Nordic countries. Soc Sci Med A 1981 0.75